In a matter of days, Pfizer CEO says they’ll be ready to ask for approval of a Covid-19 vaccine for kids

0 5
"It is a question of days, not weeks," Pfizer Chairman and CEO Albert Bourla told ABC News Sunday about when the company will submit data on children ages 5 to 11 to the FDA for consideration.Currently, Covid-19 vaccines are only approved for children 12 and older, which has stirred concern among health experts as cases in children increase, school years begin and the more transmissible Delta variant spreads.Once the data from Pfizer/BioNTech is in, it will have to go through two committees, one for the US Food and Drug Administration (FDA) and one for the CDC, CNN Medical Analyst Dr. Johnathan Reiner said Sunday. If the data comes in this week, it would likely be in committee by the end of October, he added.And there is a lot of data for them to look at, he said."This is a vaccine for children, so getting the dose right -- in terms of efficacy and side effects -- is crucial," Reiner said. But even when a vaccine becomes available, a difficult task lies ahead in getting childr
Subscribe or log in to read the rest of this content.
Leave A Reply

Your email address will not be published.

At The Centre of Every Trade
$59.95/month